McCulloch Laura, Mouat Isobel C, South Kieron, McColl Barry W, Allan Stuart M, Smith Craig J
Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Discov Immunol. 2022 Aug 11;1(1):kyac004. doi: 10.1093/discim/kyac004. eCollection 2022.
As the COVID-19 pandemic moves towards endemic disease, it remains of key importance to identify groups of individuals vulnerable to severe infection and understand the biological factors that mediate this risk. Stroke patients are at increased risk of developing severe COVID-19, likely due to stroke-induced alterations to systemic immune function. Furthermore, immune responses associated with severe COVID-19 in patients without a history of stroke parallel many of the immune alterations induced by stroke, possibly resulting in a compounding effect that contributes to worsened disease severity. In this review, we discuss the changes to systemic immune function that likely contribute to augmented COVID-19 severity in patients with a history of stroke and the effects of COVID-19 on the immune system that may exacerbate these effects.
随着新冠疫情向地方病转变,识别易发生严重感染的个体群体并了解介导这种风险的生物学因素仍然至关重要。中风患者发生重症新冠的风险增加,可能是由于中风引起的全身免疫功能改变。此外,无中风病史患者中与重症新冠相关的免疫反应与中风诱导的许多免疫改变相似,可能导致一种复合效应,促使疾病严重程度恶化。在本综述中,我们讨论了可能导致有中风病史患者新冠严重程度增加的全身免疫功能变化,以及新冠对免疫系统的影响,这些影响可能会加剧上述效应。